 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Illumina's Q4 Array Revenues Climb 4 Percent on BlueGnome Addition, HumanCore Demand
January 29, 2013
Illumina's Q4 Array Revenues Climb 4 Percent on BlueGnome Addition, HumanCore Demand
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
October 30, 2012 / BioArray News - At Investor Confab, Illumina CFO Discusses Sequestration, Japanese Market, BlueGnome
March 12, 2013 / BioArray News - At Investor Confab, Illumina Details 'Enormous' DTC Demand as Market Shifts to Less Complex Chips
May 21, 2013 / BioArray News - Illumina Saw 'Strong' Q4 Array Performance, Driven by Growth in HumanCore, Custom Products
January 8, 2013 / BioArray News - Aiming at '$12B Opportunity,' Illumina to Expand Sales Presence, Invest in Reproductive Health
May 14, 2013 / BioArray News